IA
MED icon

Inspire Advisors’s Medifast MED Stock Holding History

Inspire Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,013
Closed -$148K – 540
2025
Q1 		$148K Sell
11,013
-8,350
-43% -$125K 0.02% 426
2024
Q4 		$341K Buy
19,363
+191
+1% +$3.54K 0.04% 288
2024
Q3 		$367K Sell
19,172
-425
-2% -$8.19K 0.04% 274
2024
Q2 		$428K Sell
19,597
-13,498
-41% -$360K 0.06% 246
2024
Q1 		$1.27M Buy
33,095
+13,201
+66% +$639K 0.18% 56
2023
Q4 		$1.34M Buy
19,894
+3,008
+18% +$210K 0.2% 40
2023
Q3 		$1.26M Buy
16,886
+9,378
+125% +$832K 0.22% 40
2023
Q2 		$692K Buy
+7,508
New +$668K 0.13% 85

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Inspire Advisors's MED Position: Q2 2025 in Review

Inspire Advisors sold out of Medifast (MED) in Q2 2025, closing a stake of 11,013 shares — an estimated $148K sold.

Inspire Advisors first reported a position in MED in Q2 2023 and held it in 8 quarters. The position peaked at $1.34M in Q4 2023. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Inspire Advisors reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Inspire Advisors sold 11,013 Medifast shares in Q2 2025, an estimated $148K.
  • Inspire Advisors first reported a position in Medifast in Q2 2023 and held it in 8 quarters.
  • Inspire Advisors's Medifast position peaked at $1.34M in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Inspire Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.